comparemela.com

Latest Breaking News On - Aditya medisales - Page 1 : comparemela.com

ED Raids Premises IL&FS' Former Auditors Deloitte and KPMG Arm BSR in Money-laundering Case: Reports

The Enforcement Directorate (ED) conducted raids at the premises of KPMG arm BSR & Associates and Deloitte Haskins & Sells LLP in connection with a money-laundering probe into the alleged financial irregularities at Infrastructure Leasing & Financial Services Ltd (IL&FS). According to reports, the raids are conducted under the prevention of money laundering act (PMLA).

Mumbai
Maharashtra
India
Delhi
Bombay
Sun-pharma
Deloitte-haskins
Il-fs-transportation-networks-ltd
Economic-offences-wing-of-delhi-police
Deloitte
Infrastructure-leasing-financial-services-ltd
Il-fs-financial-services-ltd

Sun Pharma Auditors Deloitte and CJ Goswami & Associates Slapped with Rs3 Lakh Penalty by RoC in Aditya Medisales Issue

Holding Deloitte Haskins & Sells LLP and CJ Goswami & Associates, the secretarial auditor of Sun Pharmaceutical Industries Ltd (Sun Pharma), responsible for not reporting related party transactions of Sun Pharma with its sole distributor and promoter entity Aditya Medisales Ltd, the registrar of companies (RoC) in Gujarat has slapped a penalty of Rs1.50 lakh each on the audit firm and secretarial auditor of the company.

India
Dharmesh-doshi
Sudhir-valia
Kalyanasundaram-subramanian
Sun-pharma
Sailesht-desai
Dilip-shanghvi
Sunil-ajmera
Uday-baldota
Ketan-parekh
Aditya-medisales
Ashoki-bhuta

Sun Pharma Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI

BW Businessworld Sun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd. Photo Credit : Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday settled with regulator Sebi a case pertaining to alleged violation of listing obligation and disclosure requirements norms. According to separate settlement orders, Sun Pharmaceutical paid over Rs 56.11 lakh towards settlement charges and Shanghvi paid Rs 62.35 lakh.

India
Sun-pharma
Uday-baldota
Sunil-ajmera
Ashoki-bhuta
Kalyanasundaram-subramanian
Sailesht-desai
Sudhirv-valia
Dilip-shanghvi
Aditya-medisales-ltd
Sun-pharmaceutical-laboratories-ltd
Sun-pharmaceutical-industries-ltd

Stocks in the news: ITC, Bharat Forge, Sun Pharma, ACC and Motherson Sumi

Stocks in the news: ITC, Bharat Forge, Sun Pharma, ACC and Motherson Sumi SECTIONS Last Updated: Feb 12, 2021, 08:09 AM IST Share Reuters Nifty futures on the Singapore Exchange traded 13.00 points, or -0.09 per cent, lower at 15,177.50. INSIGHTS NSE Explore Now Nifty futures on the Singapore Exchange traded 13.00 points, or -0.09 per cent, lower at 15,177.50 in signs that Dalal Street was headed for a muted start on Friday. Here are a few stocks which may buzz the most in today s trade: Q3 earnings: Motherson Sumi, Bharat Forge, Glenmark Pharmaceuticals, Hindustan Aeronautics, Indiabulls Housing Finance, GMR Infrastructure, Godrej Industries and Grasim are among the companies that will report their financial results for the October-December period on Friday.

Hindustan
India-general
India
Singapore
Bharat
Sun-pharma
Aditya-medisales
Hindustan-aeronautics
Oil-india
Karur-vysya-bank
Glenmark-pharmaceuticals
Ashok-leyland

Aditya Medisales case: Sebi accepts settlement pleas of Sun Pharma, promoters

Aditya Medisales case: Sebi accepts settlement pleas of Sun Pharma, promoters SECTIONS Last Updated: Feb 11, 2021, 04:13 PM IST Share Synopsis Sebi had initiated a probe against Sun Pharma, its managing director Dilip Shanghvi and its directors on the basis of two whistleblower complaints. ET Online Sebi had initiated a probe against Sun Pharma, its managing director Dilip Shanghvi and its directors on the basis of two whistleblower complaints. INSIGHTS NSE Explore Now MUMBAI: The Securities and Exchange Board of India (Sebi) today disposed of charges against Sun Pharmaceutical Industries, and its promoters and directors for alleged diversion of funds through its subsidiary Aditya Medisales, after all the plaintiffs in the case filed a settlement plea.

Mumbai
Maharashtra
India
Sun-pharma
Uday-baldota
Dilip-shanghvi
Sunil-ajmera
Aditya-medisales
Sudhir-valia
Sun-pharmaceutical-industries
Exchange-board-of-india-sebi
Exchange-board

vimarsana © 2020. All Rights Reserved.